{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:57:28Z","timestamp":1792724248676,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10787-025-01719-9","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T14:54:33Z","timestamp":1743346473000},"page":"1775-1783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Ceramide: a central regulator in Alzheimer\u2019s disease pathogenesis"],"prefix":"10.1007","volume":"33","author":[{"given":"Priyanka","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajal","family":"Bagri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5834-0962","authenticated-orcid":false,"given":"Rahul","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"issue":"4","key":"1719_CR1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s12031-014-0423-3","volume":"54","author":"M Asle-Rousta","year":"2014","unstructured":"Asle-Rousta M et al (2014) Prominence of central sphingosine-1-phosphate receptor-1 in attenuating a\u03b2-induced injury by fingolimod. J Mol Neurosci 54(4):698\u2013703","journal-title":"J Mol Neurosci"},{"issue":"9","key":"1719_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore C, Lee VM-Y, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders. Nat Rev Neurosci 8(9):663\u2013672","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"1719_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3390\/ijms20030479","volume":"20","author":"CL Bandet","year":"2019","unstructured":"Bandet CL et al (2019) Sphingolipid metabolism: new insight into ceramide-induced lipotoxicity in muscle cells. Int J Mol Sci 20(3):479","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1719_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.imlet.2004.09.001","volume":"96","author":"T Baumruker","year":"2005","unstructured":"Baumruker T, Bornancin F, Billich A (2005) The role of sphingosine and ceramide kinases in inflammatory responses. Immunol Lett 96(2):175\u2013185","journal-title":"Immunol Lett"},{"key":"1719_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-019-1563-9","author":"G Bj\u00f8rklund","year":"2019","unstructured":"Bj\u00f8rklund G (2019) Molecular targets in Alzheimer\u2019s Disease. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-019-1563-9","journal-title":"Mol Neurobiol"},{"issue":"2","key":"1719_CR6","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s12640-017-9798-6","volume":"33","author":"J Brodowicz","year":"2018","unstructured":"Brodowicz J et al (2018) Ceramide and its related neurochemical networks as targets for some brain disorder therapies. Neurotox Res 33(2):474\u2013484","journal-title":"Neurotox Res"},{"key":"1719_CR7","first-page":"295","volume":"66","author":"H Car","year":"2012","unstructured":"Car H et al (2012) \u2018The role of ceramides in selected brain pathologies: ischemia\/hypoxia Alzheimer Disease.\u2019 Adv Hyg Exp Med 66:295\u2013303","journal-title":"Adv Hyg Exp Med"},{"issue":"7","key":"1719_CR8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/ncpneuro0549","volume":"3","author":"H Cheng","year":"2007","unstructured":"Cheng H et al (2007) Mechanisms of disease: new therapeutic strategies for Alzheimer\u2019s disease\u2014targeting APP processing in lipid rafts. Nat Clin Pract Neurol 3(7):374\u2013382","journal-title":"Nat Clin Pract Neurol"},{"issue":"8","key":"1719_CR9","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3390\/biomedicines10081956","volume":"10","author":"MR Chowdhury","year":"2022","unstructured":"Chowdhury MR, Jin HK, Bae J (2022) Diverse roles of ceramide in the progression and pathogenesis of Alzheimer\u2019s disease. Biomedicines 10(8):1956","journal-title":"Biomedicines"},{"key":"1719_CR10","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1007\/s12035-018-1448-3","volume":"56","author":"K Czubowicz","year":"2019","unstructured":"Czubowicz K et al (2019) The role of ceramide and sphingosine-1-phosphate in Alzheimer\u2019s disease and other neurodegenerative disorders. Mol Neurobiol 56:5436\u20135455","journal-title":"Mol Neurobiol"},{"issue":"11","key":"1719_CR11","first-page":"1","volume":"1","author":"PM Dapke","year":"2023","unstructured":"Dapke PM (2023) Alzheimer\u2019s disease: a review. Int J Pharm Sci 1(11):1","journal-title":"Int J Pharm Sci"},{"issue":"4","key":"1719_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2174\/156720508785132307","volume":"5","author":"A del C Alonso","year":"2008","unstructured":"del C Alonso A et al (2008) Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies. Curr Alzheimer Res 5(4):375\u2013384","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"1719_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0061988","volume":"8","author":"Y Doi","year":"2013","unstructured":"Doi Y et al (2013) Fingolimod phosphate attenuates oligomeric amyloid \u03b2-induced neurotoxicity via increased brain-derived neurotrophic factor expression in neurons. PLoS ONE 8(4):1\u201310. https:\/\/doi.org\/10.1371\/journal.pone.0061988","journal-title":"PLoS ONE"},{"issue":"8","key":"1719_CR14","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1016\/j.neurobiolaging.2013.02.001","volume":"34","author":"H Geekiyanage","year":"2013","unstructured":"Geekiyanage H, Upadhye A, Chan C (2013) Inhibition of SPT reduces A\u03b2 and tau hyperphosphorylation in a mouse model, a safe therapeutic strategy for Alzheimer\u2019s disease. Neurobiol Aging 34(8):2037","journal-title":"Neurobiol Aging"},{"key":"1719_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.plipres.2015.09.002","volume":"61","author":"A Gomez-Mu\u00f1oz","year":"2016","unstructured":"Gomez-Mu\u00f1oz A et al (2016) Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate. Prog Lipid Res 61:51\u201362","journal-title":"Prog Lipid Res"},{"key":"1719_CR16","doi-asserted-by":"crossref","unstructured":"Grande G, Vetrano DL, Mangialasche F (2018) Risk factors and prevention in Alzheimer\u2019s disease and dementia. In: Neurodegenerative diseases: clinical aspects, molecular genetics and biomarkers, pp 93\u2013112","DOI":"10.1007\/978-3-319-72938-1_6"},{"key":"1719_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117542","volume":"249","author":"M Han","year":"2020","unstructured":"Han M et al (2020) Potential sphingosine-1-phosphate-related therapeutic targets in the treatment of cerebral ischemia reperfusion injury. Life Sci 249:117542","journal-title":"Life Sci"},{"issue":"3","key":"1719_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2017.107","volume":"19","author":"YA Hannun","year":"2018","unstructured":"Hannun YA, Obeid LM (2018) Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol 19(3):175\u2013191","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"1719_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1210\/er.2007-0025","volume":"29","author":"WL Holland","year":"2008","unstructured":"Holland WL, Summers SA (2008) Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev 29(4):381\u2013402","journal-title":"Endocr Rev"},{"key":"1719_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-019-0965-z","volume":"18","author":"G Hussain","year":"2019","unstructured":"Hussain G et al (2019) Role of cholesterol and sphingolipids in brain development and neurological diseases. Lipids Health Dis 18:1\u201312","journal-title":"Lipids Health Dis"},{"issue":"3","key":"1719_CR21","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/brain\/aws013","volume":"135","author":"DJ Irwin","year":"2012","unstructured":"Irwin DJ, Cohen TJ, Grossman M, Arnold SE, Xie SX, Lee VMY, Trojanowski JQ (2012) Acetylated tau, a novel pathological signature in Alzheimer\u2019s disease and other tauopathies. Brain 135(3):807\u2013818","journal-title":"Brain"},{"key":"1719_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/346783","author":"M Jazvin\u0161\u0107ak Jembrek","year":"2015","unstructured":"Jazvin\u0161\u0107ak Jembrek M, Hof PR, \u0160imi\u0107 G (2015) Ceramides in Alzheimer\u2019s disease: key mediators of neuronal apoptosis induced by oxidative stress and A\u03b2 accumulation. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2015\/346783","journal-title":"Oxid Med Cell Longev"},{"key":"1719_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2022.101162","volume":"86","author":"LS Kalinichenko","year":"2022","unstructured":"Kalinichenko LS et al (2022) Sphingolipid control of cognitive functions in health and disease. Prog Lipid Res 86:101162","journal-title":"Prog Lipid Res"},{"issue":"1","key":"1719_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9758\/cpn.2017.15.1.1","volume":"15","author":"S Kocahan","year":"2017","unstructured":"Kocahan S, Do\u011fan Z (2017) Mechanisms of Alzheimer\u2019s disease pathogenesis and prevention: the brain, neural pathology, N-methyl-D-aspartate receptors, tau protein and other risk factors. Clin Psychopharmacol Neurosci 15(1):1","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"19","key":"1719_CR25","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1039\/C3CS60431D","volume":"43","author":"SA Kotler","year":"2014","unstructured":"Kotler SA et al (2014) Differences between amyloid-\u03b2 aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer\u2019s disease. Chem Soc Rev 43(19):6692\u20136700","journal-title":"Chem Soc Rev"},{"issue":"12","key":"1719_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.biopha.2017.12.053","volume":"98","author":"K Kumar","year":"2018","unstructured":"Kumar K et al (2018) Recent advances in the neurobiology and neuropharmacology of Alzheimer\u2019s disease. Biomedand Pharmacother 98(12):297\u2013307. https:\/\/doi.org\/10.1016\/j.biopha.2017.12.053","journal-title":"Biomedand Pharmacother"},{"key":"1719_CR27","doi-asserted-by":"publisher","first-page":"173877","DOI":"10.1016\/j.ejphar.2021.173877","volume":"895","author":"S Kumari","year":"2021","unstructured":"Kumari S, Deshmukh R (2021) \u03b2-lactam antibiotics to tame down molecular pathways of Alzheimer\u2019s disease. Eur J Pharmacol 895:173877","journal-title":"Eur J Pharmacol"},{"key":"1719_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/alz.067689","author":"S Kumari","year":"2022","unstructured":"Kumari S, Agrawal M, Deshmukh RR (2022) Fingolimod (FTY720) offers neuroprotection against AlCl3 induced experimental dementia in rats. Alzheimer\u2019s Dement. https:\/\/doi.org\/10.1002\/alz.067689","journal-title":"Alzheimer\u2019s Dement"},{"key":"1719_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-024-01638-1","author":"S Kumari","year":"2025","unstructured":"Kumari S, Bagri K, Deshmukh R (2025) Connecting dots: Preclinical foundations to clinical realities of PDE4 inhibitors in Alzheimer\u2019s disease. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-024-01638-1","journal-title":"Inflammopharmacology"},{"issue":"2","key":"1719_CR62","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.mce.2009.05.007","volume":"314","author":"M Levi","year":"2010","unstructured":"Levi M, Meijler MM, G\u00f3mez-Mu\u00f1oz A, Zor T (2010) Distinct receptor-mediated activities in macrophages for natural ceramide-1-phosphate (C1P) and for phospho-ceramide analogue-1 (PCERA-1). Mol Cell Endocrinol 314(2):248\u2013255","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"1719_CR30","first-page":"140","volume":"4","author":"B Lucke-Wold","year":"2017","unstructured":"Lucke-Wold B, Seidel K, Udo R, Omalu B, Ornstein M, Nolan R, Ross J (2017) Role of tau acetylation in Alzheimer\u2019s disease and chronic traumatic encephalopathy: the way forward for successful treatment. J Neurol Neurosurg 4(2):140","journal-title":"J Neurol Neurosurg"},{"key":"1719_CR31","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170735","author":"P Martinez Martinez","year":"2017","unstructured":"Martinez Martinez P, Mielke M (2017) Sphingolipids in Alzheimer\u2019s disease and related disorders. J Alzheimer\u2019s Dis. https:\/\/doi.org\/10.3233\/JAD-170735","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"2","key":"1719_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/mc.1043","volume":"31","author":"M Masaaki","year":"2001","unstructured":"Masaaki M et al (2001) Suppression of cell transformation and induction of apoptosis by caffeic acid phenethyl ester. Mol Carcinog 31(2):83\u201389. https:\/\/doi.org\/10.1002\/mc.1043","journal-title":"Mol Carcinog"},{"issue":"4","key":"1719_CR33","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/jnr.24781","volume":"99","author":"VK Medala","year":"2021","unstructured":"Medala VK et al (2021) Mitochondrial dysfunction, mitophagy, and role of dynamin-related protein 1 in Alzheimer\u2019s disease. J Neurosci Res 99(4):1120\u20131135. https:\/\/doi.org\/10.1002\/jnr.24781","journal-title":"J Neurosci Res"},{"issue":"3","key":"1719_CR34","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.3390\/ijms15034671","volume":"15","author":"A Mietelska-Porowska","year":"2014","unstructured":"Mietelska-Porowska A et al (2014) Tau protein modifications and interactions: their role in function and dysfunction. Int J Mol Sci 15(3):4671\u20134713. https:\/\/doi.org\/10.3390\/ijms15034671","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1719_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1084\/jem.20041685","volume":"202","author":"M Miyaji","year":"2005","unstructured":"Miyaji M et al (2005) Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis. J Exp Med 202(2):249\u2013259","journal-title":"J Exp Med"},{"issue":"11","key":"1719_CR36","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.bbalip.2016.08.016","volume":"1861","author":"MK Montgomery","year":"2016","unstructured":"Montgomery MK et al (2016) Regulation of glucose homeostasis and insulin action by ceramide acyl-chain length: a beneficial role for very long-chain sphingolipid species. Biochimica Et Biophysica Acta (BBA) Mol Cell Biol Lipids 1861(11):1828\u20131839","journal-title":"Biochimica Et Biophysica Acta (BBA) Mol Cell Biol Lipids"},{"issue":"8","key":"1719_CR37","first-page":"256","volume":"3","author":"AS Morrison","year":"2005","unstructured":"Morrison AS, Lyketsos C (2005) Review the pathophysiology of Alzheimer\u2019s disease and directions in treatment. Adv Stud Nurs 3(8):256\u2013270","journal-title":"Adv Stud Nurs"},{"issue":"4","key":"1719_CR38","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2174\/187152012800228661","volume":"12","author":"TD Mullen","year":"2012","unstructured":"Mullen TD, Obeid LM (2012) Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death. Anti-Cancer Agents Med Chem 12(4):340\u2013363","journal-title":"Anti-Cancer Agents Med Chem"},{"issue":"4","key":"1719_CR39","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/j.1476-5381.2009.00281.x","volume":"158","author":"GF Nixon","year":"2009","unstructured":"Nixon GF (2009) Sphingolipids in inflammation: pathological implications and potential therapeutic targets. Br J Pharmacol 158(4):982\u2013993","journal-title":"Br J Pharmacol"},{"issue":"5","key":"1719_CR40","doi-asserted-by":"publisher","first-page":"170069","DOI":"10.1098\/rsob.170069","volume":"7","author":"ASB Olsen","year":"2017","unstructured":"Olsen ASB, F\u00e6rgeman NJ (2017) Sphingolipids: membrane microdomains in brain development, function and neurological diseases. Open Biol 7(5):170069","journal-title":"Open Biol"},{"key":"1719_CR41","doi-asserted-by":"publisher","first-page":"1348410","DOI":"10.3389\/fphar.2024.1348410","volume":"15","author":"Y Pan","year":"2024","unstructured":"Pan Y, Li J, Lin P, Wan L, Qu Y, Cao L, Wang L (2024) A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer\u2019s disease, and their co-morbidities. Front Pharmacol 15:1348410","journal-title":"Front Pharmacol"},{"key":"1719_CR42","doi-asserted-by":"publisher","first-page":"105014","DOI":"10.1016\/j.nbd.2020.105014","volume":"143","author":"DC Pant","year":"2020","unstructured":"Pant DC, Aguilera-Albesa S, Pujol A (2020) Ceramide signalling in inherited and multifactorial brain metabolic diseases. Neurobiol Dis 143:105014","journal-title":"Neurobiol Dis"},{"issue":"4","key":"1719_CR43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2174\/1566524043360573","volume":"4","author":"BJ Pettus","year":"2004","unstructured":"Pettus BJ, Chalfant CE, Hannun YA (2004) Sphingolipids in inflammation: roles and implications. Curr Mol Med 4(4):405\u2013418","journal-title":"Curr Mol Med"},{"issue":"14","key":"1719_CR44","doi-asserted-by":"publisher","first-page":"10911","DOI":"10.1074\/jbc.M109.077610","volume":"285","author":"Y Pewzner-Jung","year":"2010","unstructured":"Pewzner-Jung Y et al (2010) A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy. J Biol Chem 285(14):10911\u201310923","journal-title":"J Biol Chem"},{"key":"1719_CR45","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12035-009-8096-6","volume":"41","author":"M Piccinini","year":"2010","unstructured":"Piccinini M et al (2010) Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders. Mol Neurobiol 41:314\u2013340","journal-title":"Mol Neurobiol"},{"issue":"11","key":"1719_CR46","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.3390\/ijms22115793","volume":"22","author":"BM Quinville","year":"2021","unstructured":"Quinville BM et al (2021) A comprehensive review: sphingolipid metabolism and implications of disruption in sphingolipid homeostasis. Int J Mol Sci 22(11):5793","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1719_CR47","doi-asserted-by":"publisher","first-page":"41231","DOI":"10.1038\/srep41231","volume":"7","author":"F Reali","year":"2017","unstructured":"Reali F et al (2017) Mechanistic interplay between ceramide and insulin resistance. Sci Rep 7(1):41231","journal-title":"Sci Rep"},{"key":"1719_CR48","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/603052","author":"JV Rushworth","year":"2011","unstructured":"Rushworth JV, Hooper NM (2011) Lipid rafts: linking Alzheimer\u2019s amyloid-\u03b2 production, aggregation, and toxicity at neuronal membranes. Int J Alzheimer\u2019s Dis. https:\/\/doi.org\/10.4061\/2011\/603052","journal-title":"Int J Alzheimer\u2019s Dis"},{"key":"1719_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.dadm.2016.02.005","volume":"3","author":"R Savica","year":"2016","unstructured":"Savica R et al (2016) Plasma sphingolipid changes with autopsy-confirmed Lewy body or Alzheimer\u2019s pathology. Alzheimer\u2019s Dement Diag, Assess Dis Monit 3:43\u201350","journal-title":"Alzheimer\u2019s Dement Diag, Assess Dis Monit"},{"key":"1719_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094850","author":"C Sharma","year":"2021","unstructured":"Sharma C et al (2021) \u2018Mitochondrial dysfunction as a driver of cognitive impairment in alzheimer\u2019s disease.\u2019 Int J Mol. https:\/\/doi.org\/10.3390\/ijms22094850","journal-title":"Int J Mol"},{"key":"1719_CR51","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fnmol.2014.00016","volume":"7","author":"J-M Sontag","year":"2014","unstructured":"Sontag J-M, Sontag E (2014) Protein phosphatase 2A dysfunction in Alzheimer\u2019s disease. Front Mol Neurosci 7:16","journal-title":"Front Mol Neurosci"},{"issue":"35","key":"1719_CR52","doi-asserted-by":"publisher","first-page":"36608","DOI":"10.1074\/jbc.M406499200","volume":"279","author":"S Stratford","year":"2004","unstructured":"Stratford S et al (2004) Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt\/protein kinase B. J Biol Chem 279(35):36608\u201336615","journal-title":"J Biol Chem"},{"issue":"1","key":"1719_CR53","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.plipres.2005.11.002","volume":"45","author":"SA Summers","year":"2006","unstructured":"Summers SA (2006) Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45(1):42\u201372","journal-title":"Prog Lipid Res"},{"issue":"1","key":"1719_CR54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40035-023-00383-9","volume":"12","author":"C Tallon","year":"2023","unstructured":"Tallon C, Bell BJ, Malvankar MM, Deme P, Nogueras-Ortiz C, Eren E, Slusher BS (2023) Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer\u2019s disease mouse model. Transl Neurodegener 12(1):56","journal-title":"Transl Neurodegener"},{"issue":"1","key":"1719_CR55","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00401-020-02234-7","volume":"141","author":"L Vaillant-Beuchot","year":"2021","unstructured":"Vaillant-Beuchot L et al (2021) Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer\u2019s disease models and human brains. Acta Neuropathol 141(1):39\u201365. https:\/\/doi.org\/10.1007\/s00401-020-02234-7","journal-title":"Acta Neuropathol"},{"key":"1719_CR56","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.51705","author":"B Vejandla","year":"2024","unstructured":"Vejandla B et al (2024) Alzheimer\u2019s disease: the past, present, and future of a globally progressive disease. Cureus. https:\/\/doi.org\/10.7759\/cureus.51705","journal-title":"Cureus"},{"issue":"7","key":"1719_CR57","doi-asserted-by":"publisher","first-page":"1900564","DOI":"10.1002\/smtd.201900564","volume":"4","author":"Y Yao","year":"2020","unstructured":"Yao Y, Ding L, Huang X (2020) Diverse functions of lipids and lipid metabolism in development. Small Methods 4(7):1900564","journal-title":"Small Methods"},{"issue":"5","key":"1719_CR58","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1089\/ars.2019.7952","volume":"34","author":"AWK Yeung","year":"2021","unstructured":"Yeung AWK et al (2021) Reactive oxygen species and their impact in neurodegenerative diseases: literature landscape analysis. Antioxid Redox Signal 34(5):402\u2013420. https:\/\/doi.org\/10.1089\/ars.2019.7952","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"1719_CR59","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.bbalip.2013.08.002","volume":"1841","author":"K Yuyama","year":"2014","unstructured":"Yuyama K, Mitsutake S, Igarashi Y (2014) Pathological roles of ceramide and its metabolites in metabolic syndrome and Alzheimer\u2019s disease. Biochimica Et Biophysica Acta (BBA) Mol Cell Biol Lipids 1841(5):793\u2013798","journal-title":"Biochimica Et Biophysica Acta (BBA) Mol Cell Biol Lipids"},{"issue":"1","key":"1719_CR63","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jbiotec.2005.10.020","volume":"123","author":"L Zhang","year":"2006","unstructured":"Zhang L, Hellgren LI, Xu X (2006) Enzymatic production of ceramide from sphingomyelin. J Biotechnol 123(1):93\u2013105","journal-title":"J Biotechnol"},{"issue":"1","key":"1719_CR60","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bbamem.2008.07.030","volume":"1788","author":"Y Zhang","year":"2009","unstructured":"Zhang Y et al (2009) Ceramide-enriched membrane domains\u2014structure and function. Biochimica Et Biophysica Acta (BBA) Biomembranes 1788(1):178\u2013183","journal-title":"Biochimica Et Biophysica Acta (BBA) Biomembranes"},{"issue":"4","key":"1719_CR61","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3233\/JAD-121879","volume":"34","author":"DC Zhu","year":"2013","unstructured":"Zhu DC et al (2013) Alzheimer\u2019s disease and amnestic mild cognitive impairment weaken connections within the default-mode network: a multi-modal imaging study. J Alzheimer\u2019s Disase 34(4):969\u2013984","journal-title":"J Alzheimer\u2019s Disase"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01719-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01719-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01719-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T01:01:30Z","timestamp":1744419690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01719-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1719"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01719-9","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}